In denying Pfizer’s motion to enjoin a lawsuit, a federal judge has said it is up to a jury to decide whether diet drugs caused a South Carolina woman’s likely fatal pulmonary hypertension to surface 11 years after she stopped taking the drugs.

Plaintiff’s counsel Michael D. Fishbein of Levin, Fishbein, Sedran & Berman said the intention of the motion by drugmaker Wyeth, now owned by Pfizer, “was to wipe out all of the federal cases.”